Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Hoe 760
2. Hoe-760
3. N-(3-(3-(n(1)-piperidinylmethyl)phenoxy)propyl)acetoxyacetamide
4. Tzu 0460
5. Tzu-0460
1. 93793-83-0
2. Roxatidine Acetate Hcl
3. Altat
4. Gastralgin
5. Hoe 760
6. Tzu-0460
7. Hoe-760
8. Roxatidine (acetate Hydrochloride)
9. Pifatidine Hydrochloride
10. Nsc-760384
11. Hoe 062 [roxatidine]
12. 60426gor1e
13. 2-acetoxy-n-(3-(m-(1-piperidinylmethyl)phenoxy)propyl)acetamide Hydrochloride
14. 2-acetoxy-n-[3-[3-(1-piperidinomethylphenoxy]propyl]acetamide Hydrochloride
15. Mfcd00941429
16. 98793-83-0
17. Neo H2
18. Dsstox_cid_26670
19. Dsstox_rid_81809
20. Dsstox_gsid_46670
21. Aceroxatidine Hydrochloride
22. 2-oxo-2-((3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)amino)ethyl Acetate Hydrochloride
23. 2-oxo-2-(3-(3-(piperidin-1-ylmethyl)phenoxy)propylamino)ethyl Acetate Hydrochloride
24. Smr000469144
25. Tzu 0460
26. Cas-93793-83-0
27. Ccris 3347
28. Ncgc00167499-01
29. Xarcin
30. Unii-60426gor1e
31. Sr-01000763240
32. Altat (tn)
33. Roxatidine Acetate Hydrochloride [usan:jan]
34. 2-hydroxy-n-(3-(m-(piperidinomethyl)phenoxy)propyl)acetamide Acetate (ester) Hydrochloride
35. Acetamide, 2-(acetyloxy)-n-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)-, Monohydrochloride
36. Acetamide, 2-hydroxy-n-(3-(m-(1-piperidinylmethyl)phenoxy)propyl)-, Acetate, Hydrochloride
37. N-(3-((alpha-piperidino-m-tolyl)oxy)propyl)glycolamide Acetate (ester), Monohydrochloride
38. Mls001401443
39. Mls002153806
40. Schembl667643
41. Chembl2104871
42. Dtxsid2046670
43. Chebi:32107
44. Hy-b0305a
45. Akp-004
46. Amy8936
47. Pharmakon1600-01502334
48. Bcp10517
49. N-(3-(3-(n(1)-piperidinylmethyl)phenoxy)propyl)acetoxyacetamide
50. Tox21_112500
51. Tox21_112954
52. Nsc760384
53. S1880
54. 2-acetoxy-n-(3-(m-(1-piperidinylmethyl)phenoxy)propyl)acetamidehydrochloride
55. Akos015894912
56. Tox21_112500_1
57. Ab07712
58. Ccg-101016
59. Nc00266
60. Nsc 760384
61. [2-oxo-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]ethyl] Acetate;hydrochloride
62. 2-(acetyloxy)-n-[3-[3-(1-piperidinyl-methyl)phenoxy]propyl]- Acetamide Monohydrochloride
63. 2-oxo-2-[[3-[3-(1-piperidylmethyl)phenoxy]propyl]amino]ethyl Acetate Hydrochloride
64. Acetamide, 2-(acetyloxy)-n-(3-(3-(1-piperidinylmethyl)phenoxy)propyl-, Monohydrochloride
65. Ncgc00167499-02
66. Ac-26444
67. Acetamide, 2-hydroxy-n-(3-(m-(piperidinomethyl)phenoxy)propyl)-, Acetate (ester), Hydrochloride
68. As-14306
69. Sy111342
70. Ft-0630983
71. R0178
72. Roxatidine Acetate Hydrochloride [mi]
73. Sw197646-3
74. Roxatidine Acetate Hydrochloride (jp17/usan)
75. Roxatidine Acetate Hydrochloride [jan]
76. C90611
77. D01467
78. Roxatidine Acetate Hydrochloride [usan]
79. 2-oxo-2-(3-(3-(piperidin-1-ylmethyl)phenoxy
80. Roxatidine Acetate Hydrochloride [mart.]
81. Roxatidine Acetate Hydrochloride [who-dd]
82. 793r830
83. A844708
84. Sr-01000763240-4
85. Q27263158
86. 2-acetoxy-n-[3-[3-(1-piperidinylmethyl)phenoxy]propyl]acetamide Hydrochloride
87. 2-oxo-2-((3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)amino)ethylacetatehydrochloride
88. N-(3-((.alpha.-piperidino-m-tolyl)oxy)propyl)glycolamide Acetate Monohydrochloride
89. [2-oxidanylidene-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]ethyl] Ethanoate Hydrochloride
90. Acetic Acid [2-oxo-2-[3-[3-(1-piperidinylmethyl)phenoxy]propylamino]ethyl] Ester Hydrochloride
Molecular Weight | 384.9 g/mol |
---|---|
Molecular Formula | C19H29ClN2O4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 10 |
Exact Mass | 384.1815851 g/mol |
Monoisotopic Mass | 384.1815851 g/mol |
Topological Polar Surface Area | 67.9 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 410 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Histamine H2 Antagonists
Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?